Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for
Kevzara Enrollment Form. If you are applying forfinancial assistance 4. All information will bekept confidential and will not be released to unauthorized parties without your consent.
Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for
Approval press release you're invited to an expert data presentation on the kevzara indication for pmr. Dob (mm/dd/yyyy)* phone* zip code* insurance informationprimary rx insurance namerx insurance phone ( ) policy id # rx bin # patient has no insurance. Kevzara is used to treat adult patients with: Please see important safety information including boxed warning, and full pi on website. Completesection 1 sign section 23. Save or instantly send your ready documents. Web now approved to treat adult patients with polymyalgia rheumatica (pmr) who have had an inadequate response to corticosteroids or who cannot tolerate corticosteroid taper. Register today when it’s time for a change, target. Web patient consent and enrollment form instructions to ensure your information is processed without delay: Kevzara (sarilumab) for pmr fax completed form to 888.302.1028.
Web patient enrolment form for more information please contact: Web patient enrolment form for more information please contact: Return all completed sections of this consent form through the patientby mail or by fax assistance program, connect Web patient consent and enrollment form instructions to ensure your information is processed without delay: Save or instantly send your ready documents. Kevzara (sarilumab) for pmr fax completed form to 888.302.1028. For questions regarding the patient assistance program, please call. Completesection 1 sign section 23. Dob (mm/dd/yyyy)* phone* zip code* insurance informationprimary rx insurance namerx insurance phone ( ) policy id # rx bin # patient has no insurance. Register today when it’s time for a change, target. Patient’s irst name last name middle initial date of birth
